News

  • Women’s Health Week Europe launches two specialised pitch competitions to accelerate innovation

    Following the success of standout alumni like Impli and Hera Biotech, Women’s Health Week Europe doubles down on innovation with two targeted startup showcases. Women’s Health Week Europe, the continent’s largest dedicated women’s health event, has announced the opening of applications for its expanded innovation showcase — now featuring two specialized pitch competitions designed to [...]

  • Pandemic disrupted women’s health more than men’s, study finds

    Women experienced greater declines in mental and physical health than men during the Covid-19 pandemic, new research has found. They reported eating fruit less frequently, smaller reductions in alcohol consumption and a sharper rise in psychological distress compared to men over the same period. Before the pandemic, women appeared to benefit more from healthy lifestyle [...]

  • What is NIPT and why are more women choosing it?

    Non-Invasive Prenatal Testing (NIPT) is becoming a common part of antenatal care across the UK. Offering a safe, highly accurate way to screen for certain genetic and chromosomal conditions in early pregnancy, NIPT is increasingly chosen by expectant parents who want clearer, earlier insight into their baby’s health. As of June 2021, NIPT has been [...]

  • Endometriosis infertility linked to higher pregnancy rates

    Women with infertility linked to endometriosis are four times more likely to become pregnant than those with infertility from other causes, a 30-year study has found. The findings analysed health records from more than four million women in England. The data showed that 40.5 per cent of those diagnosed with endometriosis had at least one [...]

  • Planned C-sections linked to leukaemia risk in children

    Children born by planned caesarean section may face a 21 per cent higher risk of developing acute lymphoblastic leukaemia (ALL) later in life, new research has found. The risk was even higher for B-cell acute lymphoblastic leukaemia (B-ALL) – the most common form of childhood blood cancer – with a 29 per cent increased risk [...]

  • Mumbai’s Luma Fertility raises US$4m seed round

    A Mumbai-based fertility health-tech startup has raised US$4m in seed funding to expand its services across the city and into other parts of India. Luma Fertility will use the investment to expand its footprint in Mumbai and later scale into other cities over the next two years. The startup operates a 6,000-square-foot facility housing a [...]

  • Round up: US$11m to accelerate breakthroughs in breast cancer research, world’s first whole-genome and transcriptome test, and more

    Femtech World explores the latest developments in business in the world of women’s health. US$11m to accelerate breakthroughs in breast cancer research Breast cancer organisation Susan G. Komen has announced today that it is awarding US$10.8m in new research grants to help propel innovation in breast cancer research. The research grants will support 25 cutting-edge [...]

  • Belfast startup launches AI period tracking tool

    A Belfast-based femtech company has launched what it claims is the world’s first AI-powered menstrual tracking system that provides clinical-grade insights into period volume, clotting and cycle trends. Joii’s technology, unveiled in Dublin, combines a specially designed menstrual pad with a mobile app to measure blood volume and clot size in millilitres – offering users [...]

  • Low social status linked to women’s heart risk

    Women who see themselves as having lower social status are more likely than other people to show early signs of heart stress in the heart’s tissue – a pattern not seen in men. The findings point to sex-specific effects, with women who rated their social standing lower displaying more signs of inflammation and early scarring [...]

  • Thousands denied breast cancer drugs over NHS rules

    Thousands of women with advanced breast cancer could miss out on life-extending treatment because of what campaigners say is an “unfair” NHS drug approval process. Health Secretary Wes Streeting is under pressure to scrap current spending rules and overhaul how the NHS decides which treatments to fund. The calls follow a decision not to approve [...]